Long-acting Beta-agonists Market Analysis

  • Report ID: 3996
  • Published Date: Aug 20, 2024
  • Report Format: PDF, PPT

Long-acting Beta-agonists Market Analysis

The market is segmented by drug type into albuterol, formoterol, salmeterol, and others, out of which, the formoterol segment is anticipated to hold a substantial share in the global long-acting beta-agonists market over the forecast period owing to the longer-lasting action of formoterol-based compositions. Moreover, formoterol is administered as an inhalation powder, which has the maximum relief effect. Such factors are expected to encourage the segment growth.

Our in-depth analysis of the global long-acting beta-agonists market includes the following segments:

        By Route of Administration

  • Inhaled
  • Injectable
  • Oral
  • Others

         By Drug Type

  • Albuterol
  • Formoterol
  • Salmeterol
  • Others

       By Application

  • Asthma
  • Bronchospasm
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Others
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3996
  • Published Date: Aug 20, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of long-acting beta-agonists is evaluated at USD 1.1 billion.

Long-acting Beta-agonists Market size was valued at USD 987.4 million in 2023 and is expected to reach USD 5.67 billion by 2036, expanding at around 14.4% CAGR during the forecast period i.e., between 2024-2036. Increasing prevalence of asthma and COPD globally is anticipated to boost the market growth.

Asia Pacific industry is expected to hold largest revenue share by 2036, driven by high prevalence of COPD, bronchospasm, and other disorders amongst the geriatric population.

The major players in the market are GlaxoSmithKline plc, Merck KGaA, Mylan N.V., Teva Pharmaceutical Industries Ltd., AstraZeneca plc, Sumitomo Dainippon Pharma Co., Ltd., Koninklijke Philips N.V., Pear Therapeutics, Inc., and Sanofi-aventis Groupe.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample